Related Experiment Video
Updated: Jul 15, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Remyelination can be extensive in multiple sclerosis despite a long disease course
R Patani1, M Balaratnam, A Vora
1Department of Cellular and Molecular Neuroscience, UK MS Tissue Bank, Division of Neuroscience, Imperial College London, Charing Cross Hospital Campus, London, UK.
Abstract:
Experimental studies using models of multiple sclerosis (MS) indicate that rapid and extensive remyelination of inflammatory demyelinated lesions is not only possible, but is the normal situation. The presence of completely remyelinated MS lesions has been noted in numerous studies and routine limited sampling of post mortem MS material suggests that remyelination may be extensive in the early stages but eventually fails. However, visual macroscopic guided sampling tends to be biased towards chronic demyelinated lesions. Here we have extensively sampled cerebral tissue from two MS cases to investigate the true extent of remyelination. Sections were cut from 185 cerebral tissue blocks and stained with haematoxylin and eosin (H&E), luxol fast blue and cresyl fast violet (LFB/CFV) and anti-myelin oligodendrocyte glycoprotein, human leucocyte antigen-DR (HLA-DR) and 200 kDa neurofilament protein antibodies. Demyelinated areas were identified in 141 blocks, comprising both white matter (WMLs) and/or grey matter lesions. In total, 168 WMLs were identified, 22% of which were shadow plaques, 73% were partially remyelinated and only 5% were completely demyelinated. The average extent of lesion remyelination for all WMLs investigated was 47%. Increased density of HLA-DR(+) macrophages and microglia at the lesion border correlated significantly with more extensive remyelination. Results from this study of two patients with long standing disease suggest that remyelination in MS may be more extensive than previously thought.
Insights
Extensive sampling of multiple sclerosis (MS) brain tissue reveals that remyelination is more common than previously thought. This finding suggests potential for new therapeutic strategies targeting myelin repair in MS patients.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Experimental models suggest rapid remyelination is typical in multiple sclerosis (MS).
- Previous studies on post-mortem MS tissue indicated remyelination may fail over time.
- Macroscopic sampling methods may overrepresent chronic demyelinated lesions.
Purpose of the Study:
- To investigate the true extent of remyelination in the cerebral tissue of two MS patients.
- To analyze demyelinated lesions in both white matter and grey matter.
- To correlate inflammatory markers with remyelination extent.
Main Methods:
- Extensive sampling of cerebral tissue from 185 blocks from two MS cases.
- Histological staining including H&E, LFB/CFV, and immunohistochemistry for myelin, immune cells (HLA-DR), and neurofilaments.
- Identification and quantification of demyelinated and remyelinated lesions (white matter lesions - WMLs).
Main Results:
- Demyelinated areas were found in 141 blocks, with 168 WMLs identified.
- Of the WMLs, 22% were shadow plaques, 73% partially remyelinated, and 5% completely demyelinated.
- Average remyelination extent across all WMLs was 47%; increased HLA-DR+ cells correlated with greater remyelination.
Conclusions:
- Results suggest remyelination in MS may be more extensive than previously assumed, even in long-standing disease.
- The findings challenge the notion of inevitable remyelination failure in MS.
- Immune cell activity at lesion borders may play a crucial role in promoting remyelination.
Related Concept Videos
Multiple Sclerosis l: Introduction
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Neurogenesis and Regeneration of Nervous Tissue
Secondary Spinal Cord Injury llI: Pathophysiology
